coronarophraphy in patients with CKD stage I-II. Methods: In randomized, sham-controlled blind study 51 patient

of one of the diabetic complications, i.e., diabetic nephropathy, was associated with the variable rs

activity against topoisomerases I and IIα, key cell cycle enzymes. Using flow cytometry, muricadienin

(rs6842241), VEGFA (–2549(18)I/D), and ADRB2 (rs1042713) polymorphic loci with hypertension, and found